The fibroblast growth factor receptor (FGFR) is a widely distributed transmembrane tyrosine kinase receptor and has four subtypes (FGFR1‐4), among which FGFR3 is the most commonly mutated in BC.12 This evidence concerns the gene FGFR3 and breast cancer.